Adstiladrin

Indicated For

high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) ±Ta/T1

About This Medication

# Ferring Access Support Patient Assistance Program Patient Guide: How to Get Adstiladrin at Low or No Cost Adstiladrin (nadofaragene firadenovec-vncg) is a groundbreaking gene therapy for certain bladder cancer patients, and the **Ferring Access Support Patient Assistance Program** helps eligible uninsured U.S. residents get it free of charge.[1] This guide explains everything you need to know about qualifying, applying, and receiving your medication. ## About Adstiladrin **Adstiladrin** is the first FDA-approved non-replicating intravesical gene therapy designed specifically for adult patients with high-risk **BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)** with carcinoma in situ (CIS), with or without papillary tumors (Ta/T1).[4] Administered directly into the bladder, it works by delivering a gene that produces interferon alfa, a protein that helps fight cancer cells. Unlike traditional chemotherapies, it's given every three months, reducing the need for frequent clinic visits and easing travel burdens.[4] Recent FDA updates allow faster thawing (about 25 minutes in a 25°C water bath), making it easier for healthcare providers to prepare and administer.[4] **Important Safety Note**: Adstiladrin is contraindicated if you have hypersensitivity to interferon alfa or any product components. Discuss risks like potential side effects with your doctor.[4] ## Who Qualifies for the Program? The **Ferring Access Support Patient Assistance Program** is needs-based and targets patients who cannot afford their medication.[1] Key eligibility factors include: - U.S. residents (including Puerto Rico).[1] - **Uninsured** (no prescription insurance coverage).[1][5] - Financial need (specific income thresholds not publicly detailed; program assesses on a case-by-case basis).[1] - Prescription for Adstiladrin for an FDA-approved use from a licensed U.S. healthcare provider.[1][3] This program does not cover patients with insurance, Medicare, or other coverage options.[1] It's ideal for those facing high out-of-pocket costs due to lack of insurance. ## Income Eligibility Breakdown Detailed income thresholds (e.g., Federal Poverty Level percentages) are not publicly specified in program materials, as eligibility is determined individually based on financial need.[1] Patients must provide proof of income during enrollment. Here's a general overview of how patient assistance programs like this typically work: | Household Size | Typical Threshold Example (e.g., 400-500% FPL)* | Notes | |---------------|------------------------------------------------|-------| | Individual | ~$60,000-$75,000 annually | Assessed case-by-case; exact limits not listed. | | Couple | ~$80,000-$100,000 annually | Proof of income required. | | Family of 3 | ~$100,000-$125,000 annually | Contact program for personalized review. | | Family of 4 | ~$120,000-$150,000 annually | *Estimates based on common PAP standards; confirm with Ferring. | *Federal Poverty Level (FPL) varies yearly. Since specifics aren't available, call the program to verify your situation.[1] ## Insurance Requirements You must be **uninsured**—no private prescription insurance, Medicare Part D, Medicaid, or other government programs that cover Adstiladrin.[1][5] Underinsured patients may explore other Ferring support options like coverage assistance, but this PAP is strictly for those without insurance.[5] If you have insurance, you won't qualify; instead, ask your provider about copay savings or bridging programs from Ferring.[2] ## Step-by-Step Application Process Applying is straightforward and done by phone—no online form listed, but enrollment is required.[1] Follow these steps: 1. **Talk to Your Doctor**: Confirm Adstiladrin is right for you and get a prescription. Your healthcare provider can guide you and may help with paperwork.[3] 2. **Call the Program**: Dial **1-844-623-6669** (Monday-Friday, 9 AM-6 PM ET) to speak with a Ferring Access Support representative.[1] They'll explain details, screen your eligibility, and start enrollment. 3. **Provide Information**: Share proof of residency (U.S./Puerto Rico), lack of insurance, income details (e.g., tax returns, pay stubs), and prescription info.[1] 4. **Submit Documents**: Fax, mail, or upload as instructed—common items include doctor's prescription, proof of income, and ID.[1] 5. **Approval Wait**: Expect a decision within days to weeks (see FAQ for details).[1] 6. **Receive Medication**: If approved, Adstiladrin ships directly to your doctor's office or pharmacy for administration.[1] The program offers free medication for eligible patients, with no activation fees.[1] ## Timeline and Delivery Processing time isn't specified publicly, but most PAPs approve within 1-4 weeks after receiving complete documents.[1] Once approved, medication is delivered promptly to your healthcare provider—no home shipment, as it's administered intravesically in a clinical setting.[1][4] Refills or reauthorization may be needed periodically; contact the program to confirm.[1] ## Alternatives if Denied If ineligible (e.g., insured or income too high): - **Ferring Coverage Support**: For underinsured patients, including copay assistance or prior authorization help.[2][5] - **General Resources**: Check NeedyMeds.org, RxAssist.org, or PAN Foundation for bladder cancer aid. - **Manufacturer Site**: Visit ferringusa.com or adstiladrin.com for other options.[2][3] - **Discuss with Doctor**: Explore clinical trials, generics (none currently), or biosimilars (not applicable).[4] ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026.[1][2][3][4][5] Program details can change; always verify with Ferring at 1-844-623-6669. Not medical advice—consult your healthcare provider. Ferring Pharmaceuticals reserves the right to modify eligibility or end the program anytime. Word count: 1028.

Program information last verified: March 30, 2026